-
1Academic Journal
المؤلفون: Staehler, Michael, Stöckle, Michael, Christoph, Daniel C., Stenzl, Arnulf, Potthoff, Karin, Grimm, Marc-Oliver, Klein, Dunja, Harde, Johanna, Brüning, Fabian, Goebell, Peter J., Augustin, Marinela, Roos, Frederik, Benz-Rüd, Iris, Marschner, Norbert, Grünwald, Viktor
مصطلحات موضوعية: ddc:610, 6-month PFS rate, everolimus, phase IV, renal cell carcinoma, second-line
Relation: https://onlinelibrary.wiley.com/action/downloadSupplement?doi=10.1002%2Fijc.33349&file=ijc33349-sup-0001-TableS1.pdf; hdl:20.500.11880/34159
-
2
المؤلفون: Iris Benz-Rüd, Frederik Roos, Marc-Oliver Grimm, Peter J. Goebell, Michael Stöckle, Norbert Marschner, Viktor Grünwald, Marinela Augustin, Michael Staehler, Dunja Klein, Daniel C. Christoph, Fabian Brüning, Karin Potthoff, Johanna Harde, Arnulf Stenzl
مصطلحات موضوعية: Male, Cancer Research, Medizin, Kaplan-Meier Estimate, Gastroenterology, Body Mass Index, 0302 clinical medicine, 6-month PFS rate, Renal cell carcinoma, Clinical endpoint, Prospective Studies, Fatigue, Aged, 80 and over, Hazard ratio, Anemia, Middle Aged, Kidney Neoplasms, Progression-Free Survival, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Female, Gastrointestinal Hemorrhage, phase IV, medicine.drug, Adult, second-line, medicine.medical_specialty, renal cell carcinoma, Antineoplastic Agents, 03 medical and health sciences, Internal medicine, medicine, Humans, ddc:610, Adverse effect, Survival rate, Carcinoma, Renal Cell, Aged, Proportional Hazards Models, Stomatitis, Everolimus, Proportional hazards model, business.industry, medicine.disease, everolimus, Receptors, Vascular Endothelial Growth Factor, business
وصف الملف: application/pdf